Rkayson Pharma Private Limited - Company Profile

It is a agriculture private limited company based in Pune, Maharashtra, India, established in 2017.
2017 Pune, Maharashtra, India Active
Last Updated:
About Rkayson Pharma Private Limited

Rkayson Pharma Private Limited, a active private limited company, was established on 10 February 2017 in Pune, Maharashtra, India. Engaging in animal feeds within the professional, scientific and technical sector, it holds CIN: U73100PN2017PTC168840. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Rajesh Jagannath Kasunde (Director), Deepa Laxmi Rajesh Kasunde (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Row House No. 59, S. No. 685/3, Bibwewadi,, Pune, Maharashtra, 411037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100PN2017PTC168840

  • Registration Number

    168840

  • Incorporation Date

    10 February 2017

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 21.18%
  • Profit Growth ****8.49%
  • Ebitda ****46.60%
  • Net Worth 29.53%
  • Total Assets -10.41%
Company report

Rkayson Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rkayson Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Rkayson Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Jagannath Kasunde Director 10 Feb 2017 Current
Deepa Laxmi Rajesh Kasunde Director 10 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rkayson Pharma.

Rkayson Pharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 21.18% increase. The company also saw a slight improvement in profitability, with a 8.49% increase in profit. The company's net worth Soared by an impressive increase of 29.53%.

Rkayson Pharma revenue growth over time
Rkayson Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
21.18%
*******
*******
*******
*******
Revenue from Operations
*******
21.18%
*******
*******
*******
*******
Total Assets
*******
-10.41%
*******
*******
*******
*******
Profit or Loss
*******
8.49%
*******
*******
*******
*******
Net Worth
*******
29.53%
*******
*******
*******
*******
EBITDA
*******
46.60%
*******
*******
*******
*******
What is the Ownership and Shareholding Structure of Rkayson Pharma?

In 2019, Rkayson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rkayson Pharma?

Unlock and access historical data on people associated with Rkayson Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rkayson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rkayson Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rkayson Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Rkayson Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Rkayson Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.

  • Director Appointment

    Progress on Rajesh Jagannath Kasunde was appointed as a Director was appointed as a Director on 10 Feb 2017 & has been associated with this company since 8 years 11 months . was documented.

  • Director Appointment

    Deepa Laxmi Rajesh Kasunde was appointed as a Director was appointed as a Director on 10 Feb 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.

  • Company Incorporation

    The activity Rkayson Pharma Private Limited was registered on 10 Feb 2017 with Roc Pune & aged 8 years 11 months as per MCA records. was completed.

Frequently Asked Questions
What is the CIN of Rkayson Pharma Private Limited?

The CIN of Rkayson Pharma Private Limited is U73100PN2017PTC168840.

Where is Rkayson Pharma Private Limited headquartered?

Rkayson Pharma Private Limited is headquartered at Row House No. 59, S. No. 685/3, Bibwewadi,, Pune, Maharashtra, 411037.

When was Rkayson Pharma Private Limited incorporated?

Rkayson Pharma Private Limited was incorporated on 10 February 2017.

Who are the current directors of Rkayson Pharma Private Limited?

The current directors of Rkayson Pharma Private Limited are

What is the primary industry of Rkayson Pharma Private Limited?

The primary industry of Rkayson Pharma Private Limited is Professional, Scientific And Technical.

Is Rkayson Pharma Private Limited a listed company?

Rkayson Pharma Private Limited is unlisted.

What is the capital structure of Rkayson Pharma Private Limited?

The authorized capital of Rkayson Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Rkayson Pharma Private Limited?

The compliance status of Rkayson Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available